WOBBLE GENOMICS LIMITEDActive
Key figures
Like most small UK companies, WOBBLE GENOMICS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Filed accounts2021/22–2024/25
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|
| Cash at bank and in hand | — | — | 6,752,597 | 3,365,143 |
| Total assets | 1,625,848 | 869,356 | — | — |
| Total liabilities | — | — | — | — |
| Net assets / total equity | 1,580,188 | 795,364 | 7,071,003 | 3,660,192 |
| Average number of employees | 6 | 13 | 15 | 21 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the Company during the financial period was research and development work relating to proprietary methods of maximising RNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.
As described in the company's latest filed accounts.
Summary: WOBBLE GENOMICS LIMITED
Company
WOBBLE GENOMICS LIMITED is a private limited company registered with Companies House under company number SC694432. It was incorporated on 6 Apr 2021. Its status is active. The registered office is in Edinburgh (EH4). Its nature of business (SIC 2007) is manufacture of other chemical products n.e.c. (20590), business and domestic software development (62012), research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files small company accounts (filleted). Net assets were £3,660,192, down 48.2% on the previous year. Cash at bank and in hand was £3,365,143. The company had an average of 21 employees. Figures are available for 4 financial years (2021/22–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 19 Apr 2027.